Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Vortioxetine Market Growth 2022-2028

  • LP 4832736
  • 74 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Vortioxetine will have significant change from previous year. According to our (LP Information) latest study, the global Vortioxetine market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Vortioxetine market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Vortioxetine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Vortioxetine market, reaching US$ million by the year 2028. As for the Europe Vortioxetine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Vortioxetine players cover Takeda, Lundbeck, CGeneTech, and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Vortioxetine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

5 Mg Tablets

10 Mg Tablet

15 Mg Tablet

20 Mg Tablet

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Depression

Generalized Anxiety Disorder

Attention Deficit Hyperactivity Disorder

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Takeda

Lundbeck

CGeneTech

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Vortioxetine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Vortioxetine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Vortioxetine by Country/Region, 2017, 2022 & 2028

2.2 Vortioxetine Segment by Type

2.2.1 5 Mg Tablets

2.2.2 10 Mg Tablet

2.2.3 15 Mg Tablet

2.2.4 20 Mg Tablet

2.3 Vortioxetine Sales by Type

2.3.1 Global Vortioxetine Sales Market Share by Type (2017-2022)

2.3.2 Global Vortioxetine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Vortioxetine Sale Price by Type (2017-2022)

2.4 Vortioxetine Segment by Application

2.4.1 Depression

2.4.2 Generalized Anxiety Disorder

2.4.3 Attention Deficit Hyperactivity Disorder

2.4.4 Other

2.5 Vortioxetine Sales by Application

2.5.1 Global Vortioxetine Sale Market Share by Application (2017-2022)

2.5.2 Global Vortioxetine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Vortioxetine Sale Price by Application (2017-2022)

3 Global Vortioxetine by Company

3.1 Global Vortioxetine Breakdown Data by Company

3.1.1 Global Vortioxetine Annual Sales by Company (2020-2022)

3.1.2 Global Vortioxetine Sales Market Share by Company (2020-2022)

3.2 Global Vortioxetine Annual Revenue by Company (2020-2022)

3.2.1 Global Vortioxetine Revenue by Company (2020-2022)

3.2.2 Global Vortioxetine Revenue Market Share by Company (2020-2022)

3.3 Global Vortioxetine Sale Price by Company

3.4 Key Manufacturers Vortioxetine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Vortioxetine Product Location Distribution

3.4.2 Players Vortioxetine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Vortioxetine by Geographic Region

4.1 World Historic Vortioxetine Market Size by Geographic Region (2017-2022)

4.1.1 Global Vortioxetine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Vortioxetine Annual Revenue by Geographic Region

4.2 World Historic Vortioxetine Market Size by Country/Region (2017-2022)

4.2.1 Global Vortioxetine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Vortioxetine Annual Revenue by Country/Region

4.3 Americas Vortioxetine Sales Growth

4.4 APAC Vortioxetine Sales Growth

4.5 Europe Vortioxetine Sales Growth

4.6 Middle East & Africa Vortioxetine Sales Growth

5 Americas

5.1 Americas Vortioxetine Sales by Country

5.1.1 Americas Vortioxetine Sales by Country (2017-2022)

5.1.2 Americas Vortioxetine Revenue by Country (2017-2022)

5.2 Americas Vortioxetine Sales by Type

5.3 Americas Vortioxetine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Vortioxetine Sales by Region

6.1.1 APAC Vortioxetine Sales by Region (2017-2022)

6.1.2 APAC Vortioxetine Revenue by Region (2017-2022)

6.2 APAC Vortioxetine Sales by Type

6.3 APAC Vortioxetine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Vortioxetine by Country

7.1.1 Europe Vortioxetine Sales by Country (2017-2022)

7.1.2 Europe Vortioxetine Revenue by Country (2017-2022)

7.2 Europe Vortioxetine Sales by Type

7.3 Europe Vortioxetine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Vortioxetine by Country

8.1.1 Middle East & Africa Vortioxetine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Vortioxetine Revenue by Country (2017-2022)

8.2 Middle East & Africa Vortioxetine Sales by Type

8.3 Middle East & Africa Vortioxetine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Vortioxetine

10.3 Manufacturing Process Analysis of Vortioxetine

10.4 Industry Chain Structure of Vortioxetine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Vortioxetine Distributors

11.3 Vortioxetine Customer

12 World Forecast Review for Vortioxetine by Geographic Region

12.1 Global Vortioxetine Market Size Forecast by Region

12.1.1 Global Vortioxetine Forecast by Region (2023-2028)

12.1.2 Global Vortioxetine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Vortioxetine Forecast by Type

12.7 Global Vortioxetine Forecast by Application

13 Key Players Analysis

13.1 Takeda

13.1.1 Takeda Company Information

13.1.2 Takeda Vortioxetine Product Offered

13.1.3 Takeda Vortioxetine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Takeda Main Business Overview

13.1.5 Takeda Latest Developments

13.2 Lundbeck

13.2.1 Lundbeck Company Information

13.2.2 Lundbeck Vortioxetine Product Offered

13.2.3 Lundbeck Vortioxetine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Lundbeck Main Business Overview

13.2.5 Lundbeck Latest Developments

13.3 CGeneTech

13.3.1 CGeneTech Company Information

13.3.2 CGeneTech Vortioxetine Product Offered

13.3.3 CGeneTech Vortioxetine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 CGeneTech Main Business Overview

13.3.5 CGeneTech Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Vortioxetine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Vortioxetine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 5 Mg Tablets

Table 4. Major Players of 10 Mg Tablet

Table 5. Major Players of 15 Mg Tablet

Table 6. Major Players of 20 Mg Tablet

Table 7. Global Vortioxetine Sales by Type (2017-2022) & (M Pcs)

Table 8. Global Vortioxetine Sales Market Share by Type (2017-2022)

Table 9. Global Vortioxetine Revenue by Type (2017-2022) & ($ million)

Table 10. Global Vortioxetine Revenue Market Share by Type (2017-2022)

Table 11. Global Vortioxetine Sale Price by Type (2017-2022) & (US$/Pcs)

Table 12. Global Vortioxetine Sales by Application (2017-2022) & (M Pcs)

Table 13. Global Vortioxetine Sales Market Share by Application (2017-2022)

Table 14. Global Vortioxetine Revenue by Application (2017-2022)

Table 15. Global Vortioxetine Revenue Market Share by Application (2017-2022)

Table 16. Global Vortioxetine Sale Price by Application (2017-2022) & (US$/Pcs)

Table 17. Global Vortioxetine Sales by Company (2020-2022) & (M Pcs)

Table 18. Global Vortioxetine Sales Market Share by Company (2020-2022)

Table 19. Global Vortioxetine Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Vortioxetine Revenue Market Share by Company (2020-2022)

Table 21. Global Vortioxetine Sale Price by Company (2020-2022) & (US$/Pcs)

Table 22. Key Manufacturers Vortioxetine Producing Area Distribution and Sales Area

Table 23. Players Vortioxetine Products Offered

Table 24. Vortioxetine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Vortioxetine Sales by Geographic Region (2017-2022) & (M Pcs)

Table 28. Global Vortioxetine Sales Market Share Geographic Region (2017-2022)

Table 29. Global Vortioxetine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Vortioxetine Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Vortioxetine Sales by Country/Region (2017-2022) & (M Pcs)

Table 32. Global Vortioxetine Sales Market Share by Country/Region (2017-2022)

Table 33. Global Vortioxetine Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Vortioxetine Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Vortioxetine Sales by Country (2017-2022) & (M Pcs)

Table 36. Americas Vortioxetine Sales Market Share by Country (2017-2022)

Table 37. Americas Vortioxetine Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Vortioxetine Revenue Market Share by Country (2017-2022)

Table 39. Americas Vortioxetine Sales by Type (2017-2022) & (M Pcs)

Table 40. Americas Vortioxetine Sales Market Share by Type (2017-2022)

Table 41. Americas Vortioxetine Sales by Application (2017-2022) & (M Pcs)

Table 42. Americas Vortioxetine Sales Market Share by Application (2017-2022)

Table 43. APAC Vortioxetine Sales by Region (2017-2022) & (M Pcs)

Table 44. APAC Vortioxetine Sales Market Share by Region (2017-2022)

Table 45. APAC Vortioxetine Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Vortioxetine Revenue Market Share by Region (2017-2022)

Table 47. APAC Vortioxetine Sales by Type (2017-2022) & (M Pcs)

Table 48. APAC Vortioxetine Sales Market Share by Type (2017-2022)

Table 49. APAC Vortioxetine Sales by Application (2017-2022) & (M Pcs)

Table 50. APAC Vortioxetine Sales Market Share by Application (2017-2022)

Table 51. Europe Vortioxetine Sales by Country (2017-2022) & (M Pcs)

Table 52. Europe Vortioxetine Sales Market Share by Country (2017-2022)

Table 53. Europe Vortioxetine Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Vortioxetine Revenue Market Share by Country (2017-2022)

Table 55. Europe Vortioxetine Sales by Type (2017-2022) & (M Pcs)

Table 56. Europe Vortioxetine Sales Market Share by Type (2017-2022)

Table 57. Europe Vortioxetine Sales by Application (2017-2022) & (M Pcs)

Table 58. Europe Vortioxetine Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Vortioxetine Sales by Country (2017-2022) & (M Pcs)

Table 60. Middle East & Africa Vortioxetine Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Vortioxetine Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Vortioxetine Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Vortioxetine Sales by Type (2017-2022) & (M Pcs)

Table 64. Middle East & Africa Vortioxetine Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Vortioxetine Sales by Application (2017-2022) & (M Pcs)

Table 66. Middle East & Africa Vortioxetine Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Vortioxetine

Table 68. Key Market Challenges & Risks of Vortioxetine

Table 69. Key Industry Trends of Vortioxetine

Table 70. Vortioxetine Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Vortioxetine Distributors List

Table 73. Vortioxetine Customer List

Table 74. Global Vortioxetine Sales Forecast by Region (2023-2028) & (M Pcs)

Table 75. Global Vortioxetine Sales Market Forecast by Region

Table 76. Global Vortioxetine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Vortioxetine Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Vortioxetine Sales Forecast by Country (2023-2028) & (M Pcs)

Table 79. Americas Vortioxetine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Vortioxetine Sales Forecast by Region (2023-2028) & (M Pcs)

Table 81. APAC Vortioxetine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Vortioxetine Sales Forecast by Country (2023-2028) & (M Pcs)

Table 83. Europe Vortioxetine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Vortioxetine Sales Forecast by Country (2023-2028) & (M Pcs)

Table 85. Middle East & Africa Vortioxetine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Vortioxetine Sales Forecast by Type (2023-2028) & (M Pcs)

Table 87. Global Vortioxetine Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Vortioxetine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Vortioxetine Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Vortioxetine Sales Forecast by Application (2023-2028) & (M Pcs)

Table 91. Global Vortioxetine Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Vortioxetine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Vortioxetine Revenue Market Share Forecast by Application (2023-2028)

Table 94. Takeda Basic Information, Vortioxetine Manufacturing Base, Sales Area and Its Competitors

Table 95. Takeda Vortioxetine Product Offered

Table 96. Takeda Vortioxetine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 97. Takeda Main Business

Table 98. Takeda Latest Developments

Table 99. Lundbeck Basic Information, Vortioxetine Manufacturing Base, Sales Area and Its Competitors

Table 100. Lundbeck Vortioxetine Product Offered

Table 101. Lundbeck Vortioxetine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 102. Lundbeck Main Business

Table 103. Lundbeck Latest Developments

Table 104. CGeneTech Basic Information, Vortioxetine Manufacturing Base, Sales Area and Its Competitors

Table 105. CGeneTech Vortioxetine Product Offered

Table 106. CGeneTech Vortioxetine Sales (M Pcs), Revenue ($ Million), Price (US$/Pcs) and Gross Margin (2020-2022)

Table 107. CGeneTech Main Business

Table 108. CGeneTech Latest Developments

List of Figures

Figure 1. Picture of Vortioxetine

Figure 2. Vortioxetine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Vortioxetine Sales Growth Rate 2017-2028 (M Pcs)

Figure 7. Global Vortioxetine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Vortioxetine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 5 Mg Tablets

Figure 10. Product Picture of 10 Mg Tablet

Figure 11. Product Picture of 15 Mg Tablet

Figure 12. Product Picture of 20 Mg Tablet

Figure 13. Global Vortioxetine Sales Market Share by Type in 2021

Figure 14. Global Vortioxetine Revenue Market Share by Type (2017-2022)

Figure 15. Vortioxetine Consumed in Depression

Figure 16. Global Vortioxetine Market: Depression (2017-2022) & (M Pcs)

Figure 17. Vortioxetine Consumed in Generalized Anxiety Disorder

Figure 18. Global Vortioxetine Market: Generalized Anxiety Disorder (2017-2022) & (M Pcs)

Figure 19. Vortioxetine Consumed in Attention Deficit Hyperactivity Disorder

Figure 20. Global Vortioxetine Market: Attention Deficit Hyperactivity Disorder (2017-2022) & (M Pcs)

Figure 21. Vortioxetine Consumed in Other

Figure 22. Global Vortioxetine Market: Other (2017-2022) & (M Pcs)

Figure 23. Global Vortioxetine Sales Market Share by Application (2017-2022)

Figure 24. Global Vortioxetine Revenue Market Share by Application in 2021

Figure 25. Vortioxetine Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Vortioxetine Revenue Market Share by Company in 2021

Figure 27. Global Vortioxetine Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Vortioxetine Revenue Market Share by Geographic Region in 2021

Figure 29. Global Vortioxetine Sales Market Share by Region (2017-2022)

Figure 30. Global Vortioxetine Revenue Market Share by Country/Region in 2021

Figure 31. Americas Vortioxetine Sales 2017-2022 (M Pcs)

Figure 32. Americas Vortioxetine Revenue 2017-2022 ($ Millions)

Figure 33. APAC Vortioxetine Sales 2017-2022 (M Pcs)

Figure 34. APAC Vortioxetine Revenue 2017-2022 ($ Millions)

Figure 35. Europe Vortioxetine Sales 2017-2022 (M Pcs)

Figure 36. Europe Vortioxetine Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Vortioxetine Sales 2017-2022 (M Pcs)

Figure 38. Middle East & Africa Vortioxetine Revenue 2017-2022 ($ Millions)

Figure 39. Americas Vortioxetine Sales Market Share by Country in 2021

Figure 40. Americas Vortioxetine Revenue Market Share by Country in 2021

Figure 41. United States Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Vortioxetine Sales Market Share by Region in 2021

Figure 46. APAC Vortioxetine Revenue Market Share by Regions in 2021

Figure 47. China Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Vortioxetine Sales Market Share by Country in 2021

Figure 54. Europe Vortioxetine Revenue Market Share by Country in 2021

Figure 55. Germany Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Vortioxetine Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Vortioxetine Revenue Market Share by Country in 2021

Figure 62. Egypt Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Vortioxetine Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Vortioxetine in 2021

Figure 68. Manufacturing Process Analysis of Vortioxetine

Figure 69. Industry Chain Structure of Vortioxetine

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390